Chemical Component Summary

Nameticlopidine
Identifiers(5S)-5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine
FormulaC14 H14 Cl N S
Molecular Weight263.79
TypeNON-POLYMER
Isomeric SMILESClc1ccccc1CN2CCc3sccc3C2
InChIInChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2
InChIKeyPHWBOXQYWZNQIN-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count31
Chiral Atom Count0
Bond Count33
Aromatic Bond Count11

Drug Info: DrugBank

DrugBank IDDB00208 
NameTiclopidine
Groupsapproved
DescriptionTiclopidine is an effective inhibitor of platelet aggregation. It is a prodrug that is metabolised to an active form, which blocks the ADP receptor that is involved in GPIIb/IIIa receptor activation leading to platelet aggregation. Ticlopidine is marketed under the brand name Ticlid and is indicated for patients who cannot take aspirin or in whom aspirin has not worked to prevent a thrombotic stroke. The FDA label includes a black-box warning of neutropenia, aplastic anemia, thrombotic thrombocytopenia purpura, and agranulocytosis, so it is necessary to monitor patients' WBC and platelets when they are taking ticlopidine.
Synonyms
  • Ticlopidina
  • Ticlopidine
  • Ticlopidine hydrochloride
  • Ticlopidinum
Brand Names
  • Ticlopidine Hydrochloride
  • Ticlopidine
  • Teva-ticlopidine
  • Nu-ticlopidine 250 mg
  • Sandoz Ticlopidine
IndicationUsed in patients, who have had a stroke or stroke precursors and who cannot take aspirin or aspirin has not worked, to try to prevent another thrombotic stroke.
Categories
  • Antiplatelet agents
  • Blood and Blood Forming Organs
  • Cardiovascular Agents
  • Chemically-Induced Disorders
  • Cytochrome P-450 CYP1A2 Inhibitors
ATC-CodeB01AC05
CAS number55142-85-3

Drug Targets

NameTarget SequencePharmacological ActionActions
P2Y purinoceptor 12MQAVDNLTSAPGNTSLCTRDYKITQVLFPLLYTVLFFVGLITNGLAMRIF...unknownantagonist
Cytochrome P450 2C19MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...unknownsubstrate,inhibitor
Cytochrome P450 2D6MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD...unknownsubstrate,inhibitor
MyeloperoxidaseMGVPFFSSLRCMVDLGPCWAGGLTAEMKLLLALAGLLAILATPQPSEGAA...unknownsubstrate
Cytochrome P450 2C9MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDI...unknowninhibitor
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem5472
ChEBICHEBI:9588
ChEMBLCHEMBL833
PharosCHEMBL833